Stereotaxis said its arrhythmia treatment program, launched in July, has already completed 70 cases, pointing to early demand for its robotic cardiac technology. The cases spanned the full arrhythmia spectrum, including patients with multiple failed procedures.
published
Stereotaxis said its arrhythmia treatment program, launched in July, has already completed 70 cases, pointing to early demand for its robotic cardiac technology. The cases spanned the full arrhythmia spectrum, including patients with multiple failed procedures
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.